GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 14, 2026, 4:00 PM EST
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $158.82 thousand as of April 15, 2026. Its market cap has decreased by -21.97% in one year.
Market Cap
158.82K
Enterprise Value
2.15M
Revenue
97.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 158.82K, a decrease of -93.73%. That is a compound annual growth rate of -20.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 158.82K | -38.01% |
| Dec 31, 2025 | 256.20K | -84.27% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 286.35K |
| Abpro Holdings | 282.49K |
| CNBX Pharmaceuticals | 245.15K |
| Ampio Pharmaceuticals | 244.10K |
| Helix BioMedix | 224.71K |
| Regen BioPharma | 210.86K |
| Innovation Pharmaceuticals | 158.63K |
| Immunotech Laboratories | 114.99K |